A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...

A health expert has weighed in the debate around so-called ‘Ozempic feet’ as people claim side effect is spotted on celebs ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped heavy drinkers cut alcohol consumption by nearly 70%.

Picture: Getty Side-effects of weight-loss drugs include nausea ... From 2023, GLP-1 drug liraglutide was included for around one in four patients. Later on, the drug semaglutide (Wegovy) was used.

Tricia Patras was diagnosed with SMA Syndrome and couldn't eat a full meal for several months after surgery. She lost 20 ...